SMALL CAP IDEA: Ananda punches above its weight with CBD-derived pain treatment

‘We punch well above our weight,’ says Jeremy Sturgess-Smith, the co-founder and finance director of Aquis-listed Ananda Developments whose CBD-derived lead asset, MRX1, is showing promise in chronic …